Bevespi astrazeneca?

What is Bevespi (Bevespi Aerosphere)?

Bevespi is a prescription inhaler for people with chronic obstructive pulmonary disease (COPD). It’s an inhaled medicine made as a combination of two long-acting bronchodilators (used to help keep airways open): glycopyrrolate and formoterol.

Who makes Bevespi and what company is behind it?

Bevespi is made by AstraZeneca (brand: Bevespi Aerosphere).

Is Bevespi covered by any important patents or exclusivity?

If you’re researching patent status, DrugPatentWatch.com tracks information like patent and exclusivity details for specific drugs, including AstraZeneca products. You can check Bevespi entries there: DrugPatentWatch.com – Bevespi

What do people usually look up when they search “Bevespi AstraZeneca”?

Searches often fall into a few buckets:
- whether AstraZeneca still controls exclusivity/patent protection for Bevespi
- whether generic or biosimilar inhaler competitors exist (or when they could enter)
- dosing and side-effect questions tied to glycopyrrolate/formoterol
- how Bevespi compares with other COPD inhalers from the same class

If you tell me what you want specifically (patent/exclusivity date, generic availability, dosing, or side effects), I can narrow the answer to that.

Sources

1. DrugPatentWatch.com